Mirum Pharmaceuticals, Inc. ($MIRM)
Filing Information
| Accession Number | 0001670138-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
49,900
Total Value
$0.00
P&L
+inf% (+$4,416,649.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | Jan 28, 2026 | Grant/Award | 18,140 | $0.00 | $0.00 | 18,140 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Units | Derivative | Jan 28, 2026 | Grant/Award | 11,760 | $0.00 | $0.00 | 11,760 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Performance Restricted Stock Units | Derivative | Jan 28, 2026 | Grant/Award | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |